Group 1: Stock Performance - Regencell Bioscience Holdings Limited (NASDAQ:RGC) slumped 42.08% this week [1] - Figma, Inc. (NYSE:FIG) fell 19.41% this week, with Morgan Stanley analyst lowering the price target from $65 to $48 [1] - Atlassian Corporation (NASDAQ:TEAM) decreased 19.82% this week, while BTIG analyst maintains a Buy rating with a $220 price target [1] - Trip.com Group Limited (NASDAQ:TCOM) fell 20.19% this week due to an investigation by China's SAMR for potential anti-monopoly violations [2] - DocuSign, Inc. (NASDAQ:DOCU) slumped 6.42% this week [2] - HubSpot, Inc. (NYSE:HUBS) decreased 16.56% this week after Morgan Stanley lowered its price target from $640 to $577 [2] - Intuit Inc. (NASDAQ:INTU) fell 14.38% this week, despite opening a new TurboTax flagship and pledging $100,000 to NYC public schools [3] - Nutanix, Inc. (NASDAQ:NTNX) fell 13.19% this week, with multiple analysts lowering their price forecasts [3] - Guidewire Software, Inc. (NYSE:GWRE) decreased 14.09% this week [3] - Summit Therapeutics Inc. (NASDAQ:SMMT) fell 14.09% this week [3]